
Humera N. Sheikh
Supervisory Patent Examiner (ID: 2074, Phone: (571)272-0604 , Office: P/1784 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615, 1618, 1793, 1784, 1789 |
| Total Applications | 839 |
| Issued Applications | 376 |
| Pending Applications | 118 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7136006
[patent_doc_number] => 20050181018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Ocular drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/105756
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8671
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105756 | Ocular drug delivery | Apr 13, 2005 | Abandoned |
Array
(
[id] => 7183112
[patent_doc_number] => 20050191350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/108009
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4174
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191350.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108009 | Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof | Apr 13, 2005 | Abandoned |
Array
(
[id] => 5721328
[patent_doc_number] => 20060074104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Use of clioquinol for the therapy of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/099693
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5857
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099693 | Use of clioquinol for the therapy of alzheimer's disease | Apr 5, 2005 | Abandoned |
Array
(
[id] => 4568231
[patent_doc_number] => 07829114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin'
[patent_app_type] => utility
[patent_app_number] => 11/076072
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22504
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829114.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076072 | Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin | Mar 8, 2005 | Issued |
Array
(
[id] => 7074410
[patent_doc_number] => 20050147678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Controlled release oral dosage form'
[patent_app_type] => utility
[patent_app_number] => 11/069435
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6078
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069435
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069435 | Controlled release oral dosage form | Feb 28, 2005 | Issued |
Array
(
[id] => 5813228
[patent_doc_number] => 20060083784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Amorphous pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/064890
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15395
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083784.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064890 | Amorphous pharmaceutical compositions | Feb 23, 2005 | Abandoned |
Array
(
[id] => 5677448
[patent_doc_number] => 20060182803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Oral sustained-release pharmaceutical composition of indapamide, production and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/060882
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2461
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060882
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060882 | Oral sustained-release pharmaceutical composition of indapamide, production and use thereof | Feb 16, 2005 | Abandoned |
Array
(
[id] => 173566
[patent_doc_number] => 07658945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/060641
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27144
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658945.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060641 | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof | Feb 15, 2005 | Issued |
Array
(
[id] => 7098572
[patent_doc_number] => 20050131031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Method of producing a nicotine composition'
[patent_app_type] => utility
[patent_app_number] => 11/045953
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1902
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131031.pdf
[firstpage_image] =>[orig_patent_app_number] => 11045953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/045953 | Method of producing a nicotine composition | Jan 26, 2005 | Abandoned |
Array
(
[id] => 7176560
[patent_doc_number] => 20050123618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Method of producing micro-capsules for the sustained release of drugs'
[patent_app_type] => utility
[patent_app_number] => 11/042682
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1610
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123618.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042682 | Method of producing micro-capsules for the sustained release of drugs | Jan 24, 2005 | Abandoned |
Array
(
[id] => 7180834
[patent_doc_number] => 20050124609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Treatment of inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 11/039958
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2651
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124609.pdf
[firstpage_image] =>[orig_patent_app_number] => 11039958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/039958 | Treatment of inflammatory bowel disease | Jan 23, 2005 | Issued |
Array
(
[id] => 7038943
[patent_doc_number] => 20050158377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Dermatologic soft gel compositions'
[patent_app_type] => utility
[patent_app_number] => 11/037120
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10541
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158377.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037120 | Dermatologic soft gel compositions | Jan 18, 2005 | Abandoned |
Array
(
[id] => 7038950
[patent_doc_number] => 20050158384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Sustained release delivery of amphetamine salts'
[patent_app_type] => utility
[patent_app_number] => 11/030174
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6146
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158384.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030174 | Sustained release delivery of amphetamine salts | Jan 6, 2005 | Abandoned |
Array
(
[id] => 7176482
[patent_doc_number] => 20050123608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Preparation of powder agglomerate'
[patent_app_type] => utility
[patent_app_number] => 11/028788
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10700
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123608.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028788 | Preparation of powder agglomerate | Jan 3, 2005 | Issued |
Array
(
[id] => 7250539
[patent_doc_number] => 20050142197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Generally linear effervescent oral fentanyl dosage form and methods of administering'
[patent_app_type] => utility
[patent_app_number] => 11/026327
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18461
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11026327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/026327 | Generally linear effervescent oral fentanyl dosage form and methods of administering | Dec 29, 2004 | Abandoned |
Array
(
[id] => 7004676
[patent_doc_number] => 20050169989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Generally linear effervescent oral fentanyl dosage form and methods of administering'
[patent_app_type] => utility
[patent_app_number] => 11/026132
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18396
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11026132
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/026132 | Generally linear effervescent oral fentanyl dosage form and methods of administering | Dec 29, 2004 | Issued |
Array
(
[id] => 4565007
[patent_doc_number] => 07858121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Effervescent oral fentanyl dosage form and methods of administering fentanyl'
[patent_app_type] => utility
[patent_app_number] => 11/027353
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18207
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858121.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027353 | Effervescent oral fentanyl dosage form and methods of administering fentanyl | Dec 29, 2004 | Issued |
Array
(
[id] => 7193474
[patent_doc_number] => 20050163838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Effervescent oral opiate dosage forms and methods of administering opiates'
[patent_app_type] => utility
[patent_app_number] => 11/026759
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14487
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163838.pdf
[firstpage_image] =>[orig_patent_app_number] => 11026759
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/026759 | Effervescent oral opiate dosage forms and methods of administering opiates | Dec 29, 2004 | Issued |
Array
(
[id] => 7074402
[patent_doc_number] => 20050147670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Oral disintegrating dosage forms'
[patent_app_type] => utility
[patent_app_number] => 11/025013
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5672
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025013 | Oral disintegrating dosage forms | Dec 29, 2004 | Abandoned |
Array
(
[id] => 5648338
[patent_doc_number] => 20060134070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Tissue regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/016017
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5630
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11016017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/016017 | Tissue regeneration | Dec 16, 2004 | Issued |